When asked what interests her more about her work – being a clinician or a researcher – Dr. Griffiths answers that both do.
Meet the Team
Nutritional needs and challenges are different for every cancer patient. Roswell Park's RDNs can make personalized recommendations to help you manage any side effects of treatment and stay healthy into the future.
“I experienced the wonderful feeling of being able to provide real hope to people suffering from cancer.”
Dr. Wooten's grandfather was diagnosed with metastatic lung cancer the summer before she began her medical education at the University of Florida College of Medicine. Her family's experience during that time has shaped the way she cares for her own patients at Roswell Park.
Work and community — two things that most people care about deeply — rarely overlap as much as they do for Rodney Haring, PhD, MSW, Director of the Department of Indigenous Cancer Health) at Roswell Park Compre
APPs are essential members of your clinical team at Roswell Park. How are they trained, and what types of things are they qualified to do?
In 2019, Pamela Hershberger, PhD, came upon a stunningly significant finding in her research lab. Dr. Hershberger, Associate Professor of Oncology in Roswell Park’s Department of Pharmacology and Therapeutics, says she and her team had been “studying patients with a particular type of lung cancer — EGFR mutant lung cancer — and their response to a specific class of drugs called EGFR tyrosine kinase inhibitors.
Roswell Park’s Christine Ambrosone, PhD, admits she may not have pursued the most conventional route to becoming a leading breast cancer researcher.
"It’s the potential to provide simple and effective methods to protect against disease and cancer. That’s what has always been very important to me.”
He won’t admit it, but Philip McCarthy, MD, is in the business of saving lives. He gives his patients hope; he gives families hope. He’s a world-renowned physician who has dedicated his career, his passion and his life to providing advanced stem cell transplants to hematological cancer patients.